Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP718822.RAAtnxDrMyfMfMxvhBjiSr8rIMQj9TxDgHjSr9R00z8eE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP718822.RAAtnxDrMyfMfMxvhBjiSr8rIMQj9TxDgHjSr9R00z8eE130_assertion type Assertion NP718822.RAAtnxDrMyfMfMxvhBjiSr8rIMQj9TxDgHjSr9R00z8eE130_head.
- NP718822.RAAtnxDrMyfMfMxvhBjiSr8rIMQj9TxDgHjSr9R00z8eE130_assertion description "[After stimulation with TLR2 and TLR4 agonists, AVICs express higher levels of pro-inflammatory and pro-osteogenic mediators (bone morphogenetic protein [BMP]-2, runt-related transcription factor 2) and greater osteogenic phenotypic changes (alkaline phosphatase [ALP] activity, calcified nodule formation) than PVICs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP718822.RAAtnxDrMyfMfMxvhBjiSr8rIMQj9TxDgHjSr9R00z8eE130_provenance.
- NP718822.RAAtnxDrMyfMfMxvhBjiSr8rIMQj9TxDgHjSr9R00z8eE130_assertion evidence source_evidence_literature NP718822.RAAtnxDrMyfMfMxvhBjiSr8rIMQj9TxDgHjSr9R00z8eE130_provenance.
- NP718822.RAAtnxDrMyfMfMxvhBjiSr8rIMQj9TxDgHjSr9R00z8eE130_assertion SIO_000772 19195606 NP718822.RAAtnxDrMyfMfMxvhBjiSr8rIMQj9TxDgHjSr9R00z8eE130_provenance.
- NP718822.RAAtnxDrMyfMfMxvhBjiSr8rIMQj9TxDgHjSr9R00z8eE130_assertion wasDerivedFrom befree-2016 NP718822.RAAtnxDrMyfMfMxvhBjiSr8rIMQj9TxDgHjSr9R00z8eE130_provenance.
- NP718822.RAAtnxDrMyfMfMxvhBjiSr8rIMQj9TxDgHjSr9R00z8eE130_assertion wasGeneratedBy ECO_0000203 NP718822.RAAtnxDrMyfMfMxvhBjiSr8rIMQj9TxDgHjSr9R00z8eE130_provenance.